Business
Johnson & Johnson : DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer
Johnson & Johnson : DePuy Synthes Appoints Christina Zamarro as Chief Financial
About this update from Johnson & Johnson
Home/ DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer June 29, 2026 June 29, 2026 Share FacebookX (Twitter)PinterestLinkedIn Copy linkRAYNHAM, Mass. (June 29, 2026) - DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced the appointment of Christina Zamarro as Chief Financial Officer, DePuy Synthes, effective July 13, 2026. Zamarro brings over 25 years of financial leadership experience serving in multitude of roles across treasury, investor relations, FP&A and accounting. She joins DePuy Synthes from the Goodyear Tire & Rubber Company, a global manufacturer, where she most recently served as the Chief Financial Officer. "I am excited to welcome Christina to the DePuy Synthes team," said Namal Nawana, Worldwide President, DePuy Synthes. "With more than two decades of financial leadership, she brings deep experience managing global and complex transformation programs. I look forward to partnering closely with Christina as we continue building on our momentum." Throughout her career, Christina has advanced through leadership roles spanning treasury, investor relations, and FP&A. She held responsibility for capital markets, liquidity, and financial risk management globally before leading investor relations and later enterprise financial planning and performance management. Christina earned an MBA from Vanderbilt University and a BA in Economics from Ohio Wesleyan University. She also serves on the board of L3Harris Technologies, where she is a member of the Audit Committee. About DePuy Synthes DePuy Synthes provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement to the millions of patients we serve. Our solutions-including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery, and sports medicine-alongside the VELYS™ Digital Surgery portfolio, are designed to support improved patient care and deliver clinical and economic value to healthcare systems worldwide. Building on a legacy of product innovation and industry firsts, we continue to shape the orthopaedic landscape through advancements in medical technologies and digital surgery across the continuum of care to Keep People Moving today and tomorrow. About Johnson & Johnson At Johnson &am...